|
1
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
Large-scale meta-analysis of cancer microarray data identifies
common transcriptional profiles of neoplastic transformation and
progression. Proc Natl Acad Sci USA. 101:9309–9314. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Jiang H, Shao J, Mao R, Liu J, Ma
Y, Fang X, Zhao N, Zheng S and Lin B: SOX4 inhibits GBM cell growth
and induces G0/G1 cell cycle arrest through Akt-p53 axis. BMC
Neurol. 14:2072014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi S, Cao X, Gu M, You B, Shan Y and You
Y: Upregulated expression of SOX4 is associated with tumor growth
and metastasis in nasopharyngeal carcinoma. Dis Markers.
2015:6581412015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu P, Ramachandran S, Seyed Ali M,
Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW,
Jaye DL, et al: Sex-determining region Y Box 4 is a transforming
oncogene in human prostate cancer cells. Cancer Res. 66:4011–4019.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoon TM, Kim SA, Cho WS, Lee DH, Lee JK,
Park YL, Lee KH, Lee JH, Kweon SS, Chung IJ, et al: SOX4 expression
is associated with treatment failure and chemoradioresistance in
oral squamous cell carcinoma. BMC Cancer. 15:8882015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hur W, Rhim H, Jung CK, Kim JD, Bae SH,
Jang JW, Yang JM, Oh ST, Kim DG, Wang HJ, et al: SOX4
overexpression regulates the p53-mediated apoptosis in
hepatocellular carcinoma: Clinical implication and functional
analysis in vitro. Carcinogenesis. 31:1298–1307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pramoonjago P, Baras AS and Moskaluk CA:
Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3
cells. Oncogene. 25:5626–5639. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bilir B, Kucuk O and Moreno CS: Wnt
signaling blockage inhibits cell proliferation and migration, and
induces apoptosis in triple-negative breast cancer cells. J Transl
Med. 11:2802013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou
T, Zhang HY, Gong WL, Yu M, Man JH, et al: Induction of SOX4 by DNA
damage is critical for p53 stabilization and function. Proc Natl
Acad Sci USA. 106:3788–3793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aaboe M, Birkenkamp-Demtroder K, Wiuf C,
Sørensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjøt L and
Ørntoft T: SOX4 expression in bladder carcinoma: Clinical aspects
and in vitro functional characterization. Cancer Res. 66:3434–3442.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Zhang Z and Li G: Patient outcome
prediction using multiple biomarkers in human melanoma: A
clinicopathological study of 118 cases. Exp Ther Med. 2:131–135.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jafarnejad SM, Wani AA, Martinka M and Li
G: Prognostic significance of Sox4 expression in human cutaneous
melanoma and its role in cell migration and invasion. Am J Pathol.
177:2741–2752. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watanabe M, Umezawa K, Higashihara M and
Horie R: Combined inhibition of NF-κB and Bcl-2 triggers
synergistic reduction of viability and induces apoptosis in
melanoma cells. Oncol Res. 21:173–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vervoort SJ, van Boxtel R and Coffer PJ:
The role of SRY-related HMG box transcription factor 4 (SOX4) in
tumorigenesis and metastasis: Friend or foe? Oncogene.
32:3397–3409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahn SG, Kim HS, Jeong SW, Kim BE, Rhim H,
Shim JY, Kim JW, Lee JH and Kim IK: Sox-4 is a positive regulator
of Hep3B and HepG2 cells' apoptosis induced by prostaglandin
(PG)A2 and Δ12-PGJ2. Exp Mol Med.
34:243–249. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahn SG, Cho GH, Jeong SY, Rhim H, Choi JY
and Kim IK: Identification of cDNAs for Sox-4, an HMG-Box protein,
and a novel human homolog of yeast splicing factor SSF-1
differentially regulated during apoptosis induced by prostaglandin
A2/Δ12-PGJ2 in Hep3B cells.
Biochem Biophys Res Commun. 260:216–221. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou Y, Wang X, Huang Y, Chen Y, Zhao G,
Yao Q, Jin C, Huang Y, Liu X and Li G: Down-regulated SOX4
expression suppresses cell proliferation, metastasis and induces
apoptosis in Xuanwei female lung cancer patients. J Cell Biochem.
116:1007–1018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jang SM, Kang EJ, Kim JW, Kim CH, An JH
and Choi KH: Transcription factor Sox4 is required for
PUMA-mediated apoptosis induced by histone deacetylase inhibitor,
TSA. Biochem Biophys Res Commun. 438:445–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng HL and Wang MJ: Effects of
microRNA-338-3p on morphine-induced apoptosis and its underlying
mechanisms. Mol Med Rep. 14:2085–2092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hur EH, Hur W, Choi JY, Kim IK, Kim HY,
Yoon SK and Rhim H: Functional identification of the pro-apoptotic
effector domain in human Sox4. Biochem Biophys Res Commun.
325:59–67. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Murtas D, Piras F, Minerba L, Ugalde J,
Piga M, Maxia C, Perra MT and Sirigu P: Nuclear factor-κB
expression is predictive of overall survival in patients with
cutaneous melanoma. Oncol Lett. 1:633–639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappaB in cancer: From innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park MH and Hong JT: Roles of NF-κB in
cancer and inflammatory diseases and their therapeutic approaches.
Cells. 5:152016. View Article : Google Scholar :
|
|
24
|
Savva CG, Totokotsopoulos S, Nicolaou KC,
Neophytou CM and Constantinou AI: Selective activation of TNFR1 and
NF-κB inhibition by a novel biyouyanagin analogue promotes
apoptosis in acute leukemia cells. BMC Cancer. 16:2792016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pahl HL: Activators and target genes of
Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tao Y, Zhang ML, Ma PC, Sun JF, Zhou WQ,
Cao YP and Li LJ: Triptolide inhibits proliferation and induces
apoptosis of human melanoma A375 cells. Asian Pac J Cancer Prev.
13:1611–1615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schneider A, Martin-Villalba A, Weih F,
Vogel J, Wirth T and Schwaninger M: NF-kappaB is activated and
promotes cell death in focal cerebral ischemia. Nat Med. 5:554–559.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li F and Ling X: Survivin study: An update
of ‘what is the next wave’? J Cell Physiol. 208:476–486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grossman D, McNiff JM, Li F and Altieri
DC: Expression and targeting of the apoptosis inhibitor, survivin,
in human melanoma. J Invest Dermatol. 113:1076–1081. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Marusawa H, Matsuzawa S, Welsh K, Zou H,
Armstrong R, Tamm I and Reed JC: HBXIP functions as a cofactor of
survivin in apoptosis suppression. EMBO J. 22:2729–2740. 2003.
View Article : Google Scholar : PubMed/NCBI
|
